Glioma-sensitive delivery of Angiopep-2 conjugated iron gold alloy nanoparticles ensuring simultaneous tumor imaging and hyperthermia mediated cancer theranostics

Hsu, S. P.C., Dhawan, U. , Tseng, Y.-Y., Lin, C.-P., Kuo, C.-Y., Wang, L.-F. and Chung, R.-J. (2020) Glioma-sensitive delivery of Angiopep-2 conjugated iron gold alloy nanoparticles ensuring simultaneous tumor imaging and hyperthermia mediated cancer theranostics. Applied Materials Today, 18, 100510. (doi: 10.1016/j.apmt.2019.100510)

Full text not currently available from Enlighten.

Abstract

Gliomas display a poor disease prognosis causing death within 15 months after diagnosis. Chemotherapy has offered some hope to target this, however, it is majorly ineffective due to the low therapeutic window, poor efficacy and high cytotoxicity. To overcome these challenges, we conjugated Angiopep-2, a cell penetrating peptide (CPP) to Iron Gold (Fe-Au) alloy nanoparticles and investigated the ability of Ang-Fe-Au Nps conjugate to limit glioma growth via magnetic field induced hyperthermia. Our results show that 6.44 nm sized conjugated Fe-Au Nps were superparamagnetic, enhanced negative Glioma image contrast and displayed a 12 °C temperature elevation when magnetically stimulated, indicating applications in medical imaging and hyperthermia-based therapy. Angiopep-2 conjugation resulted in 1.5-fold higher ingestion by C6 glioma cells than L929 fibroblasts, indicating specific glioma targeting and resulting in 90 % decrement in cell viability due to magnetic field induced hyperthermia. Immunohistochemical analysis showed an enhanced coagulative necrosis, glial fibrillary acidic protein (GFAP) expression and decreased Ki67 labelling index in rat treated with Ang-Fe-Au Nps which translated to a 5-fold decrement in tumor volume, consequently resulting in an increased survival time by 7 days. The dual application of this platform opens new doors towards cancer theranostics with minimal invasiveness.

Item Type:Articles
Additional Information:The authors are grateful for receiving financial support to conduct this study, which was funded by the Ministry of Science and Technology of Taiwan (MOST 107-2221-E-027-014; MOST 108-2628-E-027-003-MY3).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Dhawan, Dr Udesh
Authors: Hsu, S. P.C., Dhawan, U., Tseng, Y.-Y., Lin, C.-P., Kuo, C.-Y., Wang, L.-F., and Chung, R.-J.
College/School:College of Science and Engineering > School of Engineering > Biomedical Engineering
Journal Name:Applied Materials Today
Publisher:Elsevier
ISSN:2352-9407
ISSN (Online):2352-9415
Published Online:26 November 2019

University Staff: Request a correction | Enlighten Editors: Update this record